<DOC>
	<DOCNO>NCT00001563</DOCNO>
	<brief_summary>The prognosis AIDS-related Non-Hodgkin 's lymphoma poor , especially relapsed setting . There standard treatment , small study conduct report dismal outcome . The purpose study pilot use EPOCH plus rituximab previously treat AIDS-related lymphoma . Clinical endpoint study include toxicity response . Progression-free overall survival measure . Tumors evaluate p53 mutation , p-16 , bcl-2 expression , tumor proliferation , c-myc EBV possible .</brief_summary>
	<brief_title>EPOCH Chemotherapy +/- IL-12 Previously Untreated EPOCH Plus Rituximab Previously Treated Patients With AIDS-Associated Lymphoma</brief_title>
	<detailed_description>The prognosis AIDS-related Non-Hodgkin 's lymphoma poor , especially relapsed setting . There standard treatment , small study conduct report dismal outcome . The purpose study pilot use EPOCH plus rituximab previously treat AIDS-related lymphoma . Clinical endpoint study include toxicity response . Progression-free overall survival measure . Tumors evaluate p53 mutation , p-16 , bcl-2 expression , tumor proliferation , c-myc EBV possible .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , AIDS-Related</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>INCLUSION CRITERIA : Aggressive CD20 + NHL confirm Pathology , DCS . HIV + serology . All stage ( IIV ) disease . NHL previously treat two chemotherapy regimen evaluable disease . Age great equal 18 year . Laboratory test : ( Abnormalities allow due organ involvement lymphoma ) . Creatinine le equal 1.7 . Bilirubin must less 2.0 mg/dl , total bilirubin less equal 3.7 mg/dl direct fraction less equal 0.2 mg/dl indirect fraction less equal 3.5 mg/dl patient abnormality felt due protease inhibitor therapy . AST ALT less equal 3 time ULN ( AST ALT less equal 6 time ULN patient hyperalimentation abnormality felt due hyperalimentation ) . ANC great equal 1000/mm ( 3 ) . Platelets must great equal 75,000/mm ( 3 ) ( patient ITP platelet great equal 30,000/mm ( 3 ) . Signed informed consent Durable Power Attorney . EXCLUSION CRITERIA : Pregnancy nursing . History clinical heart failure symptomatic ischemic heart disease . Serious underlie medical condition infection HIV would contraindicate EPOCH . Concurrent antiretroviral therapy EPOCH therapy . Primary CNS lymphoma .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>July 28, 2016</verification_date>
	<keyword>Lymphomagenesis</keyword>
	<keyword>Molecular marker drug resistance</keyword>
	<keyword>Refractory , progressive , relapse HIV + NHL</keyword>
	<keyword>AIDS-related NHL</keyword>
</DOC>